Trading IdeasFundamentals

GKB Ophthalmics Ltd.

NSE: GKB · Medical Equipment & Supplies · sector

₹60.20NSE close 2026-10-26

Key numbers

Market cap₹30 cr
Price₹60.20
52w high / low₹76 / ₹58
P/E9.4xSector median 20.2x
P/B0.6xSector median 2.6x
Book value₹104.8
Dividend yield–Sector median 0.24%
ROE6.2%Sector median 12.4%
ROCE12.8%Sector median 13.5%
OPM5.8%Sector median 13.8%
Debt / equity0.22xSector median 0.13x
EV/EBITDA4.2xSector median 16.4x
Interest cover3.4x
Current ratio1.52x
Sales growth 3y+75.2%Sector median +12.9%
Profit growth 3y–Sector median +4.1%
PEG–

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 15 companies in Medical Equipment & Supplies (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹108.75 · low ₹51.13
Sep 2024Mar 2025Sep 2025Apr 2026Oct 2026

Quarterly results

₹ crMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue313230573033
EBITDA-313123
OPM %-9.2%2.5%10.1%2.4%5.4%8.2%
Other income000111
Net profit-4-12001
EPS (₹)7.032.023.170.880.382.00
Revenue YoY-4.0%+2.3%
Profit YoY––

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ crFY22FY23FY24FY25FY26TTM
Revenue272831109149150
EBITDA-0-1-1-379
Net profit-2-3-3-713
EPS (₹)-4.58-5.72-6.7813.982.426.43
Revenue growth+2.5%+12.4%+249.6%+36.8%–
Profit growth–––––
Dividend / share (₹)–––––
Compounded growth3 years5 yearsLast 12 months
Sales+75.2%––
Net profit–––
EPS–––
Share price–– (2y)–

Balance sheet

₹ crFY25FY26
Shareholders' equity5253
Borrowings1412
Cash & equivalents145
Total assets125132
Fixed assets1715
Capital work in progress44
Investments22
Receivables2545
Inventory5055
Payables3956

Year-end figures from the March annual filing.

Cash flow

₹ crFY25FY26
Cash from operations-3-4
Cash from investing39
Cash from financing1-6
Capex21
Free cash flow-6-5

Free cash flow = cash from operations − capex.

Ratios by year

₹ crFY25FY26
ROE %-13.5%2.3%
ROCE %-6.8%9.1%
Debtor days85110
Inventory days250189
Payable days195195
Cash conversion cycle (days)140104
Working capital days12490

Peers in Medical Equipment & Supplies

CompanyMarket capP/EP/BROEROCEOPMSales 3yDiv yield
POLYMED₹14,631 cr46.4x4.7x10.7%12.7%22.8%+18.9%0.24%
MOLBIO₹14,360 cr–––––––
TARSONS₹1,587 cr142.7x2.5x1.8%4.1%26.8%+14.3%–
LAXMIDENTL₹945 cr30.4x3.9x13.7%13.4%14.0%––
FISCHER₹856 cr11.2x2.2x-0.8%11.6%13.6%–0.04%
HSIL₹740 cr36.9x6.5x21.8%24.1%10.0%––
FABTECH₹543 cr8.8x1.3x11.6%13.6%10.9%––
PREVEST₹455 cr14.7x4.0x29.9%36.9%34.1%+12.9%0.26%
NURECA₹296 cr63.0x1.6x2.5%5.3%3.5%+9.7%–
GKB₹30 cr9.4x0.6x6.2%12.8%5.8%+75.2%–

All 15 companies in Medical Equipment & Supplies →

Dividends & corporate actions

Ex-dateActionDetail
2014-08-26OtherAnnual General Meeting
2013-08-21OtherAnnual General Meeting
2012-08-02Other30th Annual General Meeting
2011-09-21OtherAnnual General Meeting
2010-09-21DividendAnnual General Meeting And Dividend Of Rs.1.20 Per Share

Documents

Links go to the original files on the exchange website.

About the company

SectorHealthcare
IndustryMedical Equipment & Supplies
Sub-industryMedical Equipment & Supplies
SymbolGKB
BSE code533212
ISININE265D01015
Face value₹10.0
Incorporated–
Website–
Plants (India / abroad)–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years, NSE shareholding & pledge data; price = NSE close 2026-10-26.